NCT03966443
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Oslo University Hosptal Oslo, Norway
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
2,608 public trials
494 recruiting studies
Multiple Myeloma trial results
NCT03196414
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- First Affiliated Hospital, Soochow University Suzhou, Jiangsu, China
Recruiting
The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
NCT03562169
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Aberdeen Royal Infirmary Aberdeen, United Kingdom
- Monklands Hospital Airdrie, United Kingdom
- University Hospital Ayr Ayr, United Kingdom
- Barnsley Hospital Barnsley, United Kingdom
NCT02869555
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France
Enrolling by Invitation
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
NCT03689595
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Enrolling by Invitation
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
NCT05669989
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Washington University- Site Number : 8400001 St Louis, Missouri, United States
- Investigational Site Number : 0360006 Blacktown, New South Wales, Australia
- Investigational Site Number : 0360001 Saint Leonards, New South Wales, Australia
- Investigational Site Number : 0360003 Wollongong, New South Wales, Australia
Enrolling by Invitation
Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
NCT02473757
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +21 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Enrolling by Invitation
Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
NCT07499128
- Conditions
- Antibodies Bispecific, Blood Protein Disorders, Body Temperature, +36 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Enrolling by Invitation
Long-Term Follow-up Study
NCT05332054
- Conditions
- B Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, +29 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of California Irvine Irvine, California, United States
Enrolling by Invitation
AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities
NCT07410403
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Zhongnan Hospital of Wuhan University Wuhan, Hubei, China